These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. [Pay more attention to the surveillance and deal with the recurrence in ovarian cancer]. Shen K Zhonghua Fu Chan Ke Za Zhi; 2003 Nov; 38(11):657-8. PubMed ID: 14989220 [No Abstract] [Full Text] [Related]
63. [Malignant neoplasms of the ovaries]. Nickie-Psikuta M Pieleg Polozna; 1985; (7-8):2-5. PubMed ID: 3003771 [No Abstract] [Full Text] [Related]
65. Pattern of neoplasia in children--Kerala. Ramachandran G; Ramachandran P; Thangavelu M; Balaraman Nair M; Mathew KT Indian J Cancer; 1971 Dec; 8(4):250-7. PubMed ID: 4338760 [No Abstract] [Full Text] [Related]
66. Fertility preservation in young women with epithelial ovarian cancer. Wright JD; Shah M; Mathew L; Burke WM; Culhane J; Goldman N; Schiff PB; Herzog TJ Cancer; 2009 Sep; 115(18):4118-26. PubMed ID: 19670446 [TBL] [Abstract][Full Text] [Related]
67. Ovarian cancer: an overview. Roett MA; Evans P Am Fam Physician; 2009 Sep; 80(6):609-16. PubMed ID: 19817326 [TBL] [Abstract][Full Text] [Related]
68. Uptake of risk-reducing surgery in unaffected women at high risk of breast and ovarian cancer is risk, age, and time dependent. Evans DG; Lalloo F; Ashcroft L; Shenton A; Clancy T; Baildam AD; Brain A; Hopwood P; Howell A Cancer Epidemiol Biomarkers Prev; 2009 Aug; 18(8):2318-24. PubMed ID: 19661091 [TBL] [Abstract][Full Text] [Related]
69. Oestrogen receptors and small nuclear ring finger protein 4 (RNF4) in malignant ovarian germ cell tumours. Salonen J; Butzow R; Palvimo JJ; Heikinheimo M; Heikinheimo O Mol Cell Endocrinol; 2009 Aug; 307(1-2):205-10. PubMed ID: 19524139 [TBL] [Abstract][Full Text] [Related]
70. Ovarian cancer. Chobanian N; Dietrich CS Surg Clin North Am; 2008 Apr; 88(2):285-99, vi. PubMed ID: 18381114 [TBL] [Abstract][Full Text] [Related]
72. The adolescent and young adult with cancer: state of the art--epithelial cancer. Ferreira CG; de Melo AC; Nogueira-Rodrigues A Curr Oncol Rep; 2013 Aug; 15(4):287-95. PubMed ID: 23754487 [TBL] [Abstract][Full Text] [Related]
73. [Natural history of ovary cancer]. Novoa-Vargas A Ginecol Obstet Mex; 2014 Sep; 82(9):613-22. PubMed ID: 25412555 [TBL] [Abstract][Full Text] [Related]
74. Management of Rare Ovarian Cancer Histologies. Gershenson DM; Okamoto A; Ray-Coquard I J Clin Oncol; 2019 Sep; 37(27):2406-2415. PubMed ID: 31403866 [No Abstract] [Full Text] [Related]
75. Second neoplasms after invasive and borderline ovarian cancer. Levi F; Randimbison L; Blanc-Moya R; La Vecchia C Eur J Cancer Prev; 2009 Jun; 18(3):216-9. PubMed ID: 19491608 [TBL] [Abstract][Full Text] [Related]
76. Activin is a potent growth suppressor of epithelial ovarian cancer cells. Ramachandran A; Marshall ES; Love DR; Baguley BC; Shelling AN Cancer Lett; 2009 Nov; 285(2):157-65. PubMed ID: 19493612 [TBL] [Abstract][Full Text] [Related]
77. Adolescents & young adults: issues in transition from active therapy into follow-up care. Thompson K; Palmer S; Dyson G Eur J Oncol Nurs; 2009 Jul; 13(3):207-12. PubMed ID: 19539526 [TBL] [Abstract][Full Text] [Related]
78. Ovarian cancer in the young. Anteby SO; Mor-Josef S; Schenker JG Eur J Gynaecol Oncol; 1985; 6(1):41-4. PubMed ID: 2982618 [TBL] [Abstract][Full Text] [Related]
79. [Oral contraceptives give long-lasting protection against ovarian cancer. Use of oral contraceptives can explain reduced incidence of ovarian cancer in Sweden]. Milsom I; Odlind V Lakartidningen; 2008 Mar 5-11; 105(10):715-6. PubMed ID: 18422235 [No Abstract] [Full Text] [Related]
80. Prognosis and hormone receptor status in older and younger patients with advanced-stage papillary serous ovarian carcinoma. Liu JF; Hirsch MS; Lee H; Matulonis UA Gynecol Oncol; 2009 Dec; 115(3):401-6. PubMed ID: 19796795 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]